Cancer. Alzheimer’s. Precision medicine. Antibiotic-resistant bacteria. The opioid crisis. These are all areas that stand to benefit from boosted federal funding. On the other hand, other areas may take a hit — immunizations, preparedness for outbreaks and epidemics, and chronic disease prevention programs to name a few. And where does the support for basic research that drives innovation fit in? In this Forum, a panel of experts explored the promises for advancing cutting-edge treatments and research to prevent diseases that affect millions – while looking at the implications for areas where funding may be reduced. What lies ahead in the landscape for the future of medical research? Presented jointly with NBC News Digital, and part of The Andelot Series on Current Science Controversies, this Forum event took place Monday, November 6, 2017.
Cancer. Alzheimer’s. Precision medicine. Antibiotic-resistant bacteria. The opioid crisis. These are all areas that stand to benefit from boosted federal funding. On the other hand, other areas may take a hit — immunizations, preparedness for outbreaks and epidemics, and chronic disease prevention programs to name a few. And where does the support for basic research that drives innovation fit in? In this Forum, a panel of experts explored the promises for advancing cutting-edge treatments and research to prevent diseases that affect millions – while looking at the implications for areas where funding may be reduced. What lies ahead in the landscape for the future of medical research?
Presented jointly with NBC News Digital, and part of The Andelot Series on Current Science Controversies, this Forum event took place
Monday, November 6, 2017.